Home > Boards > US OTC > Alternative Energy >

United Health Products, Inc. (UEEC)

Add UEEC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/16/2018 1:43:29 PM - Followers: 23 - Board type: Free - Posts Today: 3

United Health Products, Inc.


About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit:

UEEC Security Details
Share Structure
Market Value1 $16,300,445 a/o Jun 18, 2014
Shares Outstanding 102,647,640 a/o Apr 15, 2014
Float 82,554,000 a/o Dec 31, 2012
Authorized Shares 150,000,000 a/o Mar 31, 2013
Par Value No Par Value

Who we are...

United Health Products develops, manufactures, and markets innovative products based on our proprietary hemostatic gauze core technology. Our products are distributed under the brand name HemoStyp®, and other private label names, to the trauma, dental, dialysis, and veterinary markets.

We are customer driven. We distribute our products worldwide and support our partners with ideas and solutions that will help them manage the health and safety of the people they serve. United Health Products is based in Westbury, New York and
our common stock trades under the symbol “UEEC". More about our company...

What we do...

We produce HemoStyp®, a bio-absorbable sterile gauze that will promote hemostasis almost instantly when applied to a cut or open wound. It is a patented hemostatic agent registered with the FDA to help control bleeding.

HemoStyp® contains no harmful chemicals, additives, or animal by-products and is easily removed from the wound with water or saline without compromising coagulation.

HemoStyp® is available in multiple sizes and configurations
to help control most types of bleeding including: abrasions, lacerations, and major cuts; nose bleeds; dental surgeries;
post dialysis treatment; and puncture wounds.
More about our products...

HemoStyp® is a water soluable hemostatic gauze that will produce hemostasis almost instantly when placed on a cut or open wound.
It does not contain harmful chemicals or animal by-products and is FDA registered to help stop bleeding. Once bleeding has stopped, HemoStyp® is easily removed from the wound with water or saline solution without compromising hemostasis.

HemoStyp® is extremely effective, inexpensive, and easy to use.
It is hypoallergenic and bacteriostatic and is available in multiple sizes and configurations to suit various needs and applications.

United Health Products, Inc. (UEEC) was formed to develop, produce, and market proprietary wound care products. Our core technology is a hemostatic gauze that provides the means to control bleeding from cuts and open wounds with a cost effective, high efficiency product.

This innovative technology is derived from regenerated oxidized cellulose and marketed under the trade name HemoStyp®. It is an effective, all natural hemostatic agent registered with the FDA to help control bleeding from open wounds and body cavities.

HemoStyp® is available in multiple sizes and configurations to suit various market segments and, in a healthcare sector shifting toward providing high quality care at affordable cost, offers an appealing alternative to higher priced competitive products. In addition to general military and civilian applications, the company has recently introduced Hemostyp® to the sports medicine, veterinary, dental surgery and dialysis markets.

UEEC's Chairman and CEO, Dr. Phillip Forman, has over 30 years of experience in wound care management. He leads an experienced executive management team with proven ability to develop, integrate, and grow brands in the healthcare industry. Under Dr. Forman's leadership the company will focus on market expansion, distribution, and brand awareness through:

• New contracts and strategic partnerships
• Effectively targeted marketing and advertising
• Sales excellence
• Outstanding customer support
• Key acquisitions and
• Innovative product development

New Products

We have added new configuations of our patented hemostatic gauze to our product line. The products were developed to address the specific needs of new market segments and of our existing customers, including the U.S. Military. The new products include:

Dental Gauze for oral surgery,

Four versions of Trauma Gauze™ for battlefield trauma, and

Two island dressings to support intravenous procedures.

We expect tangible contributions from all of these products as well as from the cumulative effect of an expanded product line. We will continue to identify and develop new products and configurations as we explore new markets and inundate existing ones.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
UEEC News: Current Report Filing (8-k) 12/05/2017 08:01:31 AM
UEEC News: Quarterly Report (10-q) 11/14/2017 04:08:37 PM
UEEC News: Quarterly Report (10-q) 08/21/2017 04:33:23 PM
UEEC News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/15/2017 02:50:55 PM
UEEC News: Quarterly Report (10-q) 07/31/2017 04:29:47 PM
#674   Not BIEL but interesting. Robotic Surgery MD are JHOGG 01/16/18 01:43:29 PM
#673   Sounds like Biel and the actipatch FDA approval! rodman 01/16/18 07:25:22 AM
#672   Between UEEC and another speculative holding I’m tapped JHOGG 01/16/18 01:59:22 AM
#671   I might pick up more if I see DR5 01/15/18 04:02:47 PM
#670   Positive news Wednesday and we run past $2 rodman 01/15/18 01:34:04 PM
#669   Ponder this CAN/SHOULD United Health go it alone? rodman 01/13/18 11:11:48 AM
#668   Yeah...there wasn’t any big accumulation at the end DR5 01/12/18 04:43:13 PM
#667   So when there is a buy say all Amim 01/12/18 04:19:43 PM
#666   Only able to fill 5025/5476 out of my rodman 01/12/18 03:44:09 PM
#665   Agreed...assuming that everything goes well with the FDA DR5 01/12/18 01:32:47 PM
#664   Even at $1 a buyout at $3 can rodman 01/12/18 01:22:38 PM
#663   I have a friend who is a PharmD DR5 01/12/18 12:49:40 PM
#662   Watch some big buys come in at the rodman 01/12/18 12:43:28 PM
#661   Good question? First company will need to release rodman 01/12/18 11:32:32 AM
#660   When you think value will occur after the 17? Amim 01/12/18 11:19:44 AM
#659   Do your D/D! After all its a penny rodman 01/12/18 10:35:01 AM
#658   I believe 6-7 imo Amim 01/11/18 05:52:54 PM
#657   So rough estimation annual earning basis around $200M? JHOGG 01/11/18 04:37:42 PM
#656   A little on the high side! IMO $3-5/SH. rodman 01/11/18 04:13:24 PM
#655   How soon after approval (fingers crossed) will acquisition JHOGG 01/11/18 03:29:05 PM
#654   Looking forward to good news!!!! Sarasota, FL, Dec. 12, JHOGG 01/11/18 03:10:54 PM
#653   Correction that FDA meeting is 1/17/18 next wednesday..... rodman 01/11/18 02:11:33 PM
#652   Buy on the news! rodman 01/11/18 01:34:26 PM
#651   Good luck and I will advise if I rodman 01/11/18 10:56:32 AM
#650   Want it to drop just a bit so Amim 01/11/18 09:52:56 AM
#649   Premarket is 1.05 bid and 1.10 ask. We rodman 01/11/18 08:37:41 AM
#648   Me too! I had a limit order DR5 01/10/18 06:31:42 PM
#647   Copy that and could kick myself missing that.75 yesterday! rodman 01/10/18 06:02:51 PM
#646   I'm waiting for dip so I can buy Amim 01/10/18 04:16:18 PM
#645   It’s consolidating on support, it’s all good buying Impacto 01/10/18 03:52:55 PM
#644   Little manipulation going on here! Watch for the rodman 01/10/18 03:41:12 PM
#643   1/18 was the announced meeting date to be? rodman 01/10/18 03:19:46 PM
#642   :) Impacto 01/10/18 01:10:55 PM
#641   What’s the estimated decision date?!? Thanks as JHOGG 01/10/18 01:08:01 PM
#640   Nice recovery. You were spot on. I take JHOGG 01/10/18 01:06:30 PM
#639   Lock and LOAD for a coming FDA approval. rodman 01/10/18 10:38:01 AM
#637   Wait...maybe be so if they decide to become DR5 01/09/18 04:55:36 PM
#636   Naa.....don’t think so...but, you can dream! lol DR5 01/09/18 04:51:32 PM
#635   This stock will one day be as valuable Amim 01/09/18 04:25:58 PM
#634   Got that right! rodman 01/09/18 02:56:36 PM
#633   Day not over yet, son :) Impacto 01/09/18 02:17:34 PM
#632   Solid prediction. No more remarks from impacto please.... JHOGG 01/09/18 01:54:59 PM
#631   I would have to agree and will be DR5 01/09/18 01:46:13 PM
#630   The shear fact the FDA selected UEEC for rodman 01/09/18 01:41:45 PM
#629   If you did your research about the company Amim 01/09/18 01:09:48 PM
#628   What you witnessed is not untypical of the rodman 01/09/18 12:38:45 PM
#627   We’ll close green today imo ;) Impacto 01/09/18 12:13:59 PM
#626   Couple morons sold then stop loses got triggered, Impacto 01/09/18 12:11:12 PM
#625   Impacto is correct. The public doesn't know anything. trusttheman 01/09/18 11:52:03 AM
#624   Perfect time to add imo ;) Impacto 01/09/18 11:46:41 AM